T2	Participants 576 710	As part of a randomized, double-blind, placebo-controlled relapse-prevention study of fluoxetine monotherapy in BP II MDE, 37 patients
T1	Participants 171 225	bipolar type II (BP II) major depressive episode (MDE)
